| A549 | Human lung adenocarcinoma epithelial cell line |
| A2780 | Human ovarian cancer cells line |
| AMPK | AMP-Activated protein kinase |
| ARPE-19 | Retinal pigment epithelial cell line |
| ATR | Adenosine triphosphate |
| BV2 | Microglia cells |
| BxPC-3 | Human pancreas adenocarcinoma cell line |
| Calu-1 | Human nonsmall-cell lung cancer cell line |
| CD | Circular dichroism |
| CH2Cl2 | Dichloromethane |
| CHCl3 | Chloroform |
| CHOP, CCAAT | Enhancer-binding protein homologous protein |
| CNV | Choroidal neovascularization |
| CRT | β-catenin response transcription |
| DLD-1 | Human colorectal cancer cell line |
| DR4 | Death receptor 4 |
| DR5 | Death receptor 5 |
| DPPH | 1,1-Diphenyl-2-picrylhydrazyl |
| EC50 | Half-maximal effective concentration |
| ERK | Extracellular signal-regulated kinase |
| EtOH | Ethanol |
| EtOAc | Ethyl acetate |
| FST | Porsolt forced swim test |
| FRET | Fluorescence resonance energy transfer |
| FP | Fluorescence polarization |
| GCMS | Gas chromatography mass spectrometry |
| GIAO | Gauge-invariant atomic orbital |
| GI50 | The concentration for 50% of maximal inhibition of cell |
| HCT-116 | Human colon cancer cell line |
| HEK293 | Human embryonic kidney cell |
| HepG2 | Human liver cancer cell line |
| Hepa59T/VGH | Human liver carcinoma cell line |
| HeLa | Human cervical epitheloid carcinoma cell line |
| HL-60 | Human promyelocytic leukemia cell line |
| HPLC | High-performance liquid chromatography |
| HT-29 | Human colon cancer cell line |
| hTERT-RPE1 | Retinal pigment epithelial cell lines |
| HuCCA-1 | Human cholangiocarcinoma cell line |
| HUVECs | Human umbilical vein endothelial cell line |
| HUVSMCs | Human umbilical vein smooth muscle cells line |
| IC50 | Half-maximal inhibitory concentration |
| ICL | Microbial enzyme isocitrate lyase |
| K562 | Human immortalized myelogenous leukemia cell line |
| KB | Human oral epidermoid carcinoma cell line |
| L1210 | Mouse lymphocytic leukemia cell line |
| LC31 | Human lung squamous adenocarcinoma cell line |
| LC50 | Lethal concentration 50 |
| LC–MS–NMR | Liquid chromatography–mass spectrometry–nuclear magnetic resonance |
| LD50 | Half maximal lethal concentration |
| LPS | Lipopolysaccharide |
| LLC | Murine Lewis lung carcinoma |
| L-NMMA | Nitric oxide synthase inhibitor NG-monomethyl-L-arginine |
| LU-1 | Human lung carcinoma cell line |
| MCF-7 | Human breast cancer cell line |
| MDA-MB-231 | Human breast cancer cell line |
| MeOH | Methanol |
| MG-63 | Human osteosarcoma cell line |
| MIC | Minimum inhibitory concentration |
| MOLT-3 | Human T lymphoblast cell line |
| MTS | (3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazoliuminner salt) |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| nAMD | Neovascular age-related macular degeneration |
| n-BuOH | n-Butanol |
| NMR | Nuclear magnetic resonance |
| NO | Nitric oxide |
| p38 MAPK | p38 Mitogen-activated protein kinase |
| P 388 | Human leukemia cell line |
| PANC-1 | Human pancreas ductal carcinoma cell line |
| PARP | Poly-AD Pribose polymerase |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| PDHA1 | Phosphorylation of its E1α subunit |
| RKO | Human colon cancer cell line |
| ROS | Reactive oxygen species |
| RTCA | xCELLigence system real-time cell analyzer |
| RP-18 | Reversed phase-18 |
| SRB | Sulforhodamine B |
| SiO2 CC | Silica gel column chromatography |
| SK-MEL-2 | Human melanoma cell line |
| SRB | Sulforhodamine B |
| SW480 | Human colorectal cancer cell line |
| TLC | Thin layer chromatography |
| TRAIL | Tumor necrosis factor-related apoptosis-inducing ligand |
| UPLC–MS | Ultra performance liquid chromatography–tandem mass spectrometer |